DE69128760T2 - Antidiarrhoeika - Google Patents

Antidiarrhoeika

Info

Publication number
DE69128760T2
DE69128760T2 DE69128760T DE69128760T DE69128760T2 DE 69128760 T2 DE69128760 T2 DE 69128760T2 DE 69128760 T DE69128760 T DE 69128760T DE 69128760 T DE69128760 T DE 69128760T DE 69128760 T2 DE69128760 T2 DE 69128760T2
Authority
DE
Germany
Prior art keywords
loperamide hydrochloride
antidiarrheal
syrup
saccharide
loperamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69128760T
Other languages
German (de)
English (en)
Other versions
DE69128760D1 (de
Inventor
Katsumi Imamori
Akira Iwasa
Toshiaki Kurazumi
Hiroyuki Mizuno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSP Co Ltd
Original Assignee
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SSP Co Ltd filed Critical SSP Co Ltd
Publication of DE69128760D1 publication Critical patent/DE69128760D1/de
Application granted granted Critical
Publication of DE69128760T2 publication Critical patent/DE69128760T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69128760T 1990-10-24 1991-10-22 Antidiarrhoeika Expired - Fee Related DE69128760T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2286458A JP2711759B2 (ja) 1990-10-24 1990-10-24 止瀉剤組成物

Publications (2)

Publication Number Publication Date
DE69128760D1 DE69128760D1 (de) 1998-02-26
DE69128760T2 true DE69128760T2 (de) 1998-04-30

Family

ID=17704653

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69128760T Expired - Fee Related DE69128760T2 (de) 1990-10-24 1991-10-22 Antidiarrhoeika

Country Status (8)

Country Link
US (2) US5182112A (https=)
EP (1) EP0482580B1 (https=)
JP (1) JP2711759B2 (https=)
KR (1) KR0149029B1 (https=)
CA (1) CA2054017A1 (https=)
DE (1) DE69128760T2 (https=)
ES (1) ES2113358T3 (https=)
TW (1) TW201690B (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2711759B2 (ja) * 1990-10-24 1998-02-10 エスエス製薬 株式会社 止瀉剤組成物
JP2860729B2 (ja) * 1992-03-10 1999-02-24 エスエス製薬株式会社 プラノプロフェン懸濁シロップ剤
US6726928B2 (en) * 1994-10-28 2004-04-27 R.P. Scherer Technologies, Inc. Process for preparing solid dosage forms for unpalatable pharmaceuticals
US5667773A (en) * 1996-03-12 1997-09-16 Adolor Corporation Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic conditions therewith
US5888494A (en) * 1996-03-12 1999-03-30 Adolor Corporation Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic and pruritic conditions therewith
US5849762A (en) * 1997-07-14 1998-12-15 Adolor Corporation Peripherally acting anti-pruritic opiates
US6353004B1 (en) 1997-07-14 2002-03-05 Adolor Coporation Peripherally acting anti-pruritic opiates
US20040202714A1 (en) * 1999-10-12 2004-10-14 Daiichi Suntory Pharma Co., Ltd. Oral pharmaceutical composition
JP4731777B2 (ja) * 1999-10-12 2011-07-27 マルホ株式会社 経口医薬組成物
US6365152B1 (en) 2001-03-15 2002-04-02 Bovine Health Products, Inc. Scours treatment and method of making same
FR2845600B1 (fr) * 2002-10-09 2005-07-08 Innovations Pharma Ag Composition de traitement et de rehydratation pour limiter les effets secondaires des gastro-enterites chez l'adulte
KR20050001548A (ko) * 2003-06-25 2005-01-07 동화약품공업주식회사 항설사용 약제학적 조성물
EP2131811B1 (fr) * 2007-03-14 2020-03-04 Vetinnov Produit appétent
FR2913601B1 (fr) * 2007-03-14 2009-10-30 Vetinnov Sarl Support appetent a formule amelioree
ITRM20120341A1 (it) 2012-07-17 2014-01-18 Er La Salute Della Donna E Del Bambino Soluzione glucosalina di mantenimento per la somministrazione parenterale ad uso pediatrico
US9675587B2 (en) 2013-03-14 2017-06-13 Allergan Holdings Unlimited Company Opioid receptor modulator dosage formulations
CN104546736A (zh) * 2014-12-25 2015-04-29 北京科源创欣科技有限公司 小儿盐酸洛哌丁胺颗粒及其制备工艺
JP7459458B2 (ja) * 2018-06-28 2024-04-02 ライオン株式会社 内服組成物及びその製造方法
CN111450050A (zh) * 2019-01-22 2020-07-28 北京万全德众医药生物技术有限公司 盐酸洛哌丁胺口服溶液及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU571011B2 (en) * 1983-10-07 1988-03-31 State Of Victoria, The Treatment of neonatal calf diarrhoea
US4666716A (en) * 1984-09-04 1987-05-19 Richardson-Vicks Inc. Antidiarrheal compositions and use thereof
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
US4824853A (en) * 1985-10-11 1989-04-25 Janssen Pharmaceutica N.V. α,α-diaryl-4-aryl-4-hydroxy-1-piperidinebutanamide, N-oxides and method of treating diarrhea
JPS62138147A (ja) * 1985-12-12 1987-06-20 Snow Brand Milk Prod Co Ltd ガラクトオリゴ糖類配合飼料
JP2831004B2 (ja) * 1988-09-29 1998-12-02 大日本製薬株式会社 粉粒状医薬製剤
GB8908361D0 (en) * 1989-04-13 1989-06-01 Beecham Group Plc Composition
US5219573A (en) * 1989-10-17 1993-06-15 Hershey Foods Corporation L-sugar laxatives
NZ235876A (en) * 1989-11-01 1992-06-25 Mcneil Ppc Inc Pharmaceutical compositions containing effective amount of antidiarrheal composition and antiflatulent effective amount of simethicone
JP2711759B2 (ja) * 1990-10-24 1998-02-10 エスエス製薬 株式会社 止瀉剤組成物

Also Published As

Publication number Publication date
JP2711759B2 (ja) 1998-02-10
EP0482580B1 (en) 1998-01-21
US5182112A (en) 1993-01-26
EP0482580A1 (en) 1992-04-29
KR0149029B1 (ko) 1998-10-15
DE69128760D1 (de) 1998-02-26
US5348744A (en) 1994-09-20
JPH04159223A (ja) 1992-06-02
KR920007627A (ko) 1992-05-27
CA2054017A1 (en) 1992-04-25
TW201690B (https=) 1993-03-11
ES2113358T3 (es) 1998-05-01

Similar Documents

Publication Publication Date Title
DE69128760T2 (de) Antidiarrhoeika
DE3915347C2 (de) Harzadsorbate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
DE68905096T2 (de) Niacin und guar-mehl enthaltende zusammensetzung.
DE3874917T2 (de) Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
DE2845326C2 (de) Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung
DE69009684T2 (de) Pharmazeutische Zusammensetzungen zur Behandlung gastrointestinaler Störungen.
EP0128482A2 (de) Neue galenische Zubereitungsformen von oralen Antidiabetika und Verfahren zu ihrer Herstellung
DE69224684T2 (de) Verbesserte und dosierte orale Formulierungen von Dideoxypurinenukleosiden
EP0761207A2 (de) Pharmazeutische, oral anwendbare Zubereitung enthaltend antaciden Wirkstoffe
DE3115086A1 (de) "dextromethorphan enthaltende pharamzeutische zusammensetzung und die verwendung von dextromethorphan zur schmerzbekaempfung"
DE2217132A1 (de) Festes, oral einzunehmendes Arznei mittel
DE68906765T2 (de) Zusammensetzung mit einem extrakt,das durch extraktion mit einem wasserhaltigen organischen loesungsmittel erhalten wurde und verfahren zu seiner herstellung.
DE60224202T2 (de) Erhöhte löslichkeit von flavanolignanzubereitungen
EP0722719B1 (de) Verfahren zur Herstellung von Flavano-Lignan-Zubereitungen
DE2823174A1 (de) Arzneimittel fuer die prophylaktische behandlung postoperativer tiefer venenthrombose
WO2009036906A1 (de) Zusammensetzung mit wirkstoffkombination aus einem laxans und einem entschäumer zur behandlung von obstipation
DE2758942A1 (de) Kautabletten mit einem gehalt an erythromycin
EP1001756B1 (de) Synergistisch wirkende zusammensetzungen zur selektiven bekämpfung von tumorgewebe
DE2715384C3 (de) Arzneimittel gegen Diarrhöen
DE69525348T2 (de) Medikament gegen myotonische dystrophie
DE3141970C2 (https=)
DE69528068T2 (de) Conagenine zur prävention und behandlung von diarrhöe
DE3040042A1 (de) Pharmazeutische zubereitung des tiaramids oder seiner pharmazeutisch vertraeglichen salze
DE60308595T2 (de) Flüssige Antazida
DE2157201B2 (de) Verbesserte feste orale Applikationsform von Raubasin

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee